The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111082826 11108282 6 F 201502 20160909 20150512 20160914 EXP PHJP2015JP007239 NOVARTIS 75.90 YR F Y 0.00000 20160914 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111082826 11108282 1 PS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 540 MG Y 22334 10 MG TABLET QD
111082826 11108282 2 C AROMASIN EXEMESTANE 1 Oral 25 MG, QD 1350 MG Y 0 25 MG TABLET QD
111082826 11108282 3 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 Oral 15 MG, 8:00, 20:00 U 0 15 MG TABLET BID
111082826 11108282 4 C CALONAL ACETAMINOPHEN 1 Oral 600 MG, AFTER EVERY MEAL AND AT BEDTIME U 0 600 MG TABLET QID
111082826 11108282 5 C LYRICA PREGABALIN 1 Oral 225 MG AFTER DINNER, 150MG AT BEDTIME U 0 225 MG CAPSULE
111082826 11108282 6 C FUROSEMIDE. FUROSEMIDE 1 Oral 40 MG, AFTER BREAKFAST U 0 40 MG QD
111082826 11108282 7 C PROTECADIN LAFUTIDINE 1 Oral 10 MG, AFTER BREAKFAST AND AT BEDTIME U 0 10 MG TABLET BID
111082826 11108282 8 C ZOLPIDEM TARTRATE. ZOLPIDEM TARTRATE 1 Oral 5 MG, AT BEDTIME U 0 5 MG TABLET QD
111082826 11108282 9 C MAGMITT MAGNESIUM OXIDE 1 Oral 500 MG, AFTER EVERY MEAL AND AT BEDTIME U 0 500 MG TABLET QID
111082826 11108282 10 C SENNOSIDE SENNOSIDES 1 Oral 24 MG, AT BEDTIME U 0 24 MG TABLET QD
111082826 11108282 11 C AZUNOL ST 2 Oropharingeal UNK UNK, TID U 0 MOUTHWASH TID
111082826 11108282 12 C KENALOG IN ORABASE TRIAMCINOLONE ACETONIDE 1 Unknown UNK UNK, TID U 0 TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111082826 11108282 1 Breast cancer metastatic
111082826 11108282 2 Breast cancer metastatic
111082826 11108282 3 Product used for unknown indication
111082826 11108282 4 Product used for unknown indication
111082826 11108282 5 Product used for unknown indication
111082826 11108282 6 Product used for unknown indication
111082826 11108282 7 Product used for unknown indication
111082826 11108282 8 Product used for unknown indication
111082826 11108282 9 Product used for unknown indication
111082826 11108282 10 Product used for unknown indication
111082826 11108282 11 Product used for unknown indication
111082826 11108282 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
111082826 11108282 OT
111082826 11108282 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
111082826 11108282 Condition aggravated
111082826 11108282 Food aversion
111082826 11108282 Malaise
111082826 11108282 Melaena
111082826 11108282 Oral pain
111082826 11108282 Shock haemorrhagic
111082826 11108282 Small intestinal ulcer haemorrhage
111082826 11108282 Small intestine ulcer
111082826 11108282 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111082826 11108282 1 20150108 20150302 0
111082826 11108282 2 20150108 20150302 0